Steve E Kalloger

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

Fan Zhang, Yiling Lu, Gordon B Mills, 2014, BMC Cancer.

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

Francesmary Modugno, Christine Chow, Ellen L Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Anna Adamiak, Russell Vang, C Blake Gilks, 2009, BMC Cancer.

Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer

Wen-Lin Kuo, Gordon B Mills, Jane Fridlyand, 2007, Clinical Cancer Research.

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

Nhu Le, C Blake Gilks, N. Le, 2008, Human pathology.

Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study

Samuel Leung, C Blake Gilks, David G Huntsman, 2010, The American journal of surgical pathology.

Amplification of 11q13 in ovarian carcinoma

C Blake Gilks, Joe Gray, David G Huntsman, 2008, Genes, chromosomes & cancer.

Reproducibility of histological cell type in high-grade endometrial carcinoma

M. Köbel, S. Kalloger, P. Clement, 2013, Modern Pathology.

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Sohrab P Shah, Jiarui Ding, Janine Senz, 2012, Modern Pathology.